TO-O-1001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TO-O-1001, covering 2023-10-19 to 2023-10-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]